Back
Eaton Vance Enhanced Equity Income Fund II Vs. PTC Therapeutics Industry Stock Comparison
Buy
91
EOS
Eaton Vance Enhanced Equity Income Fund II
Last Price:
21.99
Seasonality Move:
-0.98%
Sell
40
PTCT
PTC Therapeutics
Last Price:
30.47
Seasonality Move:
8.11%
Buy
91
Eaton Vance Enhanced Equity Income Fund II (EOS)
is a Buy
Is Eaton Vance Enhanced Equity Income Fund II a Buy, Sell or Hold?
- The current Eaton Vance Enhanced Equity Income Fund II [EOS] share price is $21.85. The Score for EOS is 91, which is 82% above its historic median score of 50, and infers lower risk than normal.
- EOS is currently trading in the 90-100% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Sell
40
PTC Therapeutics (PTCT)
is a Sell
Is PTC Therapeutics a Buy, Sell or Hold?
- The current PTC Therapeutics [PTCT] share price is $31.17. The Score for PTCT is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
- PTCT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
EOS Stock Price Chart
What is Eaton Vance Enhanced Equity Income Fund II's stock price today?
-
The Eaton Vance Enhanced Equity Income Fund II share price today is $21.85
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EOS is experiencing slight selling pressure.
PTCT Stock Price Chart
What is PTC Therapeutics's stock price today?
-
The PTC Therapeutics share price today is $31.17
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PTCT is experiencing slight buying pressure.
EOS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.28 | Buy |
| Relative Strength Index (14 RSI): | 67.21 | Buy |
| Chaikin Money Flow: | -18824 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (20.87 - 21.67) | Buy |
| Bollinger Bands (100): | (19.78 - 21.04) | Buy |
PTCT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.53 | Sell |
| Relative Strength Index (14 RSI): | 37.27 | Sell |
| Chaikin Money Flow: | 51415 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (34 - 37.72) | Sell |
| Bollinger Bands (100): | (26.7 - 35.2) | Buy |
EOS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 21.65 | Buy |
| 20-day SMA: | 21.41 | Buy |
| 50-day SMA: | 20.76 | Buy |
| 200-day SMA: | 19.2 | Buy |
| 8-day EMA: | 21.68 | Buy |
| 20-day EMA: | 21.42 | Buy |
| 50-day EMA: | 20.94 | Buy |
| 200-day EMA: | 19.58 | Buy |
PTCT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 34.02 | Sell |
| 20-day SMA: | 35.78 | Sell |
| 50-day SMA: | 33.9 | Sell |
| 200-day SMA: | 27.61 | Buy |
| 8-day EMA: | 33.59 | Sell |
| 20-day EMA: | 34.77 | Sell |
| 50-day EMA: | 33.84 | Sell |
| 200-day EMA: | 31.82 | Sell |
Eaton Vance Enhanced Equity Income Fund II Earnings Growth & EOS Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
PTC Therapeutics Earnings Growth & PTCT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.04 per share, an increase this year of $0.53 per share, and an increase next year of $2.47 per share.
Eaton Vance Enhanced Equity Income Fund II Technical Analysis
| Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | Jul 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
PTC Therapeutics Technical Analysis
| Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | Jul 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||